These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26625944)

  • 1. Transformable liquid-metal nanomedicine.
    Lu Y; Hu Q; Lin Y; Pacardo DB; Wang C; Sun W; Ligler FS; Dickey MD; Gu Z
    Nat Commun; 2015 Dec; 6():10066. PubMed ID: 26625944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Doxorubicin-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery.
    Du Y; Xia L; Jo A; Davis RM; Bissel P; Ehrich MF; Kingston DGI
    Bioconjug Chem; 2018 Feb; 29(2):420-430. PubMed ID: 29261297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
    Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
    Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shape-Transformable, Fusible Rodlike Swimming Liquid Metal Nanomachine.
    Wang D; Gao C; Wang W; Sun M; Guo B; Xie H; He Q
    ACS Nano; 2018 Oct; 12(10):10212-10220. PubMed ID: 30231200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo.
    Chen WH; Xu XD; Jia HZ; Lei Q; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
    Biomaterials; 2013 Nov; 34(34):8798-807. PubMed ID: 23932289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shape tunable gallium nanorods mediated tumor enhanced ablation through near-infrared photothermal therapy.
    Sun X; Sun M; Liu M; Yuan B; Gao W; Rao W; Liu J
    Nanoscale; 2019 Feb; 11(6):2655-2667. PubMed ID: 30601530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vehicle-saving theranostic probes based on hydrophobic iron oxide nanoclusters using doxorubicin as a phase transfer agent for MRI and chemotherapy.
    Cao Y; Min J; Zheng D; Li J; Xue Y; Yu F; Wu M
    Chem Commun (Camb); 2019 Aug; 55(61):9015-9018. PubMed ID: 31290867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].
    Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
    Nat Commun; 2015 Dec; 6():10081. PubMed ID: 26621191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
    Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
    Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor-targeted chemotherapy of lung cancer.
    Liang X; Liang X
    Kaohsiung J Med Sci; 2021 May; 37(5):411-418. PubMed ID: 33340254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.